GSK: Protocol Summaries: Compounds

Protocol Summaries: GSK1399686

Protocol Summaries for GSK1399686
GSK Study ID	Phase	Title	Status
111406	Phase 1	A First Time In Human Study to Evaluate the Safety, Tolerability and Pharmacokinetics of GSK1399686 after Single and Repeated Oral Dosing in Healthy Volunteers Using a Dose-Escalating, Randomized, Placebo-Controlled Study Design	Completed
111407	Phase 2	A Double-Blind, Double-Dummy, Placebo- and Active-Controlled Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Anti-Inflammatory Effects of GSK1399686 in Patients with Mild to Moderately Active Ulcerative Colitis	Recruiting

By Phase:

By Study Type:

By Population:

By Post Marketing Commitment:

By Status:

By Country: